Grant: Engage Grants Program
McGill University
$25,000.00
Determination of in vivo antioxidant effects associated with intake of specific probiotic strains
FY 2010-11
Summary
Micropharma involves the utilization of probiotic bacteria with specific enzymatic activity for the treatment of metabolic conditions such as hypercholesterolemia, hypertension, diabetes and metabolic syndrome. By utilizing a mechanistic based selection process, Micropharma can better select effective microorganisms for the treatment or prevention of metabolic diseases. The present research will explore the utility of specific bacterial species to improve antioxidant status.
Program
Engage Grants Program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
411206-2010
Name nom
Kubow, Stan
Department département
Dietetics and Human Nutrition, School of
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2010
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
1
Nb partie
1
Application title
Determination of in vivo antioxidant effects associated with intake of specific probiotic strains
Keyword
NSERC
Application summary
Micropharma involves the utilization of probiotic bacteria with specific enzymatic activity for the treatment of metabolic conditions such as hypercholesterolemia, hypertension, diabetes and metabolic syndrome. By utilizing a mechanistic based selection process, Micropharma can better select effective microorganisms for the treatment or prevention of metabolic diseases. The present research will explore the utility of specific bacterial species to improve antioxidant status.